Iovance Biotherapeutics

Go sign green light

Biotech

FDA lifts hold on Iovance's lung cancer cell therapy trial

Iovance ended 2023 on a downer courtesy of a partial clinical hold from the FDA, but the situation has been resolved relatively quickly.

James Waldron Mar 4, 2024 9:44am

red light stop light street traffic signal

Iovance cell therapy trial hit with FDA hold after patient death

Dec 29, 2023 10:29am

calendar hour glass wait delay months

FDA resource constraints delay decision on Iovance cell therapy

Sep 15, 2023 5:20am

long road journey highway desert mountains path

Iovance gets FDA ok for accelerated review of lung cancer drug

Jul 10, 2023 10:40am

Wall Street

Iovance sinks as pivotal cell therapy data disappoint investors

May 27, 2022 8:27am

runway takeoff airport cleared go

Path cleared for Iovance's melanoma drug after FDA feedback

Apr 6, 2022 10:35am